What's Happening?
Andelyn Biosciences Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the creation of The Andelyn Foundation. This nonprofit organization is dedicated to supporting families affected by rare and ultra-rare
diseases through awareness, fundraising, and community engagement. With over 10,000 rare diseases identified globally, affecting approximately 1 in 10 Americans, the foundation aims to address the lack of FDA-approved treatments for 95% of these conditions. The foundation's mission is to provide financial support to patient-founded organizations, raise awareness, and foster community engagement. The annual Fore One Purpose Golf Tournament is a key event that brings together partners, sponsors, and advocates to support families facing rare diseases.
Why It's Important?
The establishment of The Andelyn Foundation is significant as it addresses the critical need for support and awareness for families dealing with rare diseases. These families often face long journeys of misdiagnoses and limited treatment options, becoming advocates and researchers themselves. By providing financial support and amplifying their stories, the foundation aims to reduce the isolation felt by those affected and foster a supportive community. This initiative not only highlights the human stories behind scientific research but also emphasizes the importance of compassion in healthcare. The foundation's efforts could lead to increased funding and research opportunities, potentially accelerating the development of treatments for rare diseases.
What's Next?
The Andelyn Foundation plans to continue its support through annual events like the Fore One Purpose Golf Tournament, with the next event scheduled for August 24, 2026, at The Country Club at Muirfield Village in Dublin, Ohio. This event will gather community sponsors, partners, and donors to support a selected family organization. The foundation aims to expand its impact by increasing awareness and financial support for patient-founded organizations, ensuring that families navigating rare diseases feel recognized and supported. Future initiatives may include collaborations with other organizations and increased advocacy efforts to further the foundation's mission.
